Editorial Credit: Gil C / Shutterstock.com
Analyzing Google searches to uncover previously unknown adverse events isn’t news, per se, but it looks like it could be gaining traction with the FDA. According to a recent Bloomberg article, the FDA’s public calendar shows that several employees from Google met with the FDA to discuss the possibility of leveraging Google to help with signal detection.
The article states:
“FDA spokesman Chris Kelly called the meeting an introduction and a chance ‘for the agency to begin a discussion on how we might collaborate with Google on identifying adverse event data, using Google’s technologies and data.’”
Did you know that you too can leverage Google Search to find information at your company? Join us for our upcoming “Google Search for Life Sciences” webinar to learn more.